# INtensity of OVarian Stimualtion and Euploid Embryos

> **NCT06154083** · PHASE4 · RECRUITING · sponsor: **Fundación Santiago Dexeus Font** · enrollment: 110 (estimated)

## Conditions studied

- Fertility

## Interventions

- **DRUG:** Follitropin-delta (Rekovelle) 20 mcg/day from D1
- **DRUG:** Follitropin-delta (Rekovelle) 15 mcg/day from D1

## Key facts

- **NCT ID:** NCT06154083
- **Lead sponsor:** Fundación Santiago Dexeus Font
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06154083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06154083, "INtensity of OVarian Stimualtion and Euploid Embryos". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06154083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*